NO900531L - Ekspresjonssystemer for amideringsenzymer. - Google Patents
Ekspresjonssystemer for amideringsenzymer.Info
- Publication number
- NO900531L NO900531L NO90900531A NO900531A NO900531L NO 900531 L NO900531 L NO 900531L NO 90900531 A NO90900531 A NO 90900531A NO 900531 A NO900531 A NO 900531A NO 900531 L NO900531 L NO 900531L
- Authority
- NO
- Norway
- Prior art keywords
- expression systems
- amidating enzyme
- amidation
- enzymes
- amidation enzymes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/17—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced ascorbate as one donor, and incorporation of one atom of oxygen (1.14.17)
- C12Y114/17003—Peptidylglycine monooxygenase (1.14.17.3)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Hardware Redundancy (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/307,366 US5789234A (en) | 1987-08-14 | 1989-02-06 | Expression systems for amidating enzyme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO900531D0 NO900531D0 (no) | 1990-02-05 |
| NO900531L true NO900531L (no) | 1990-08-07 |
Family
ID=23189439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90900531A NO900531L (no) | 1989-02-06 | 1990-02-05 | Ekspresjonssystemer for amideringsenzymer. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5789234A (de) |
| EP (1) | EP0382403B1 (de) |
| JP (1) | JPH0771498B2 (de) |
| KR (1) | KR0157983B1 (de) |
| AT (1) | ATE283922T1 (de) |
| CA (1) | CA2009306C (de) |
| DE (1) | DE69034179T2 (de) |
| DK (1) | DK0382403T3 (de) |
| ES (1) | ES2235149T3 (de) |
| FI (1) | FI110517B (de) |
| HU (1) | HU220464B1 (de) |
| LT (1) | LT4077B (de) |
| NO (1) | NO900531L (de) |
| RU (1) | RU2129606C1 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5789234A (en) * | 1987-08-14 | 1998-08-04 | Unigene Laboratories, Inc. | Expression systems for amidating enzyme |
| US5912014A (en) * | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
| WO1998046722A1 (en) | 1997-04-16 | 1998-10-22 | Unigene Laboratories Inc. | Direct expression of peptides into culture media |
| US8088734B2 (en) | 2003-01-21 | 2012-01-03 | Unigene Laboratories Inc. | Oral delivery of peptides |
| KR101234439B1 (ko) * | 2003-09-25 | 2013-02-18 | 몬산토 테크놀로지 엘엘씨 | 단백질 내로의 비―표준 아미노산의 도입 방지 |
| US7531518B2 (en) | 2004-05-14 | 2009-05-12 | Unigene Laboratories Inc. | Method for fostering bone formation and preservation |
| US7648965B2 (en) * | 2004-05-14 | 2010-01-19 | Unigene Laboratories Inc. | Method for fostering bone formation and preservation |
| US20060089723A1 (en) * | 2004-10-25 | 2006-04-27 | Murphy Kieran P | Method for bone augmentation |
| US7445911B2 (en) | 2004-11-24 | 2008-11-04 | Unigene Laboratories Inc. | Enzymatic reactions in the presence of keto acids |
| DE102004058306A1 (de) * | 2004-12-01 | 2006-07-27 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Carboxy-terminal amidierten Peptiden |
| PA8660701A1 (es) | 2005-02-04 | 2006-09-22 | Pfizer Prod Inc | Agonistas de pyy y sus usos |
| WO2006084111A2 (en) * | 2005-02-04 | 2006-08-10 | Glaxo Group Limited | Optimization of heterologous polypeptide expression |
| US20060293667A1 (en) * | 2005-05-19 | 2006-12-28 | Agnes Vignery | Bone implant device and methods of using same |
| AU2006261909B2 (en) * | 2005-06-24 | 2011-08-11 | Enteris Biopharma, Inc. | Cell lines for expressing enzyme useful in the preparation of amidated products |
| US8377863B2 (en) | 2007-05-29 | 2013-02-19 | Unigene Laboratories Inc. | Peptide pharmaceutical for oral delivery |
| ES2622877T3 (es) | 2009-01-22 | 2017-07-07 | Keybioscience Ag | Tratamiento para la obesidad |
| WO2011067283A1 (en) | 2009-12-01 | 2011-06-09 | Novo Nordisk A/S | Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases |
| TW201138808A (en) | 2010-05-03 | 2011-11-16 | Bristol Myers Squibb Co | Serum albumin binding molecules |
| US9102753B2 (en) | 2011-06-15 | 2015-08-11 | Ugp Therapeutics, Inc. | Anti-inflammatory pharmaceutical products |
| US9533022B2 (en) | 2011-11-02 | 2017-01-03 | KeyBioscience A/S | Peptide analogs for treating diseases and disorders |
| US9006172B2 (en) | 2011-11-02 | 2015-04-14 | Keybioscience Ag | Peptide analogs for treating diseases and disorders |
| EP3357540A1 (de) | 2011-11-02 | 2018-08-08 | KeyBioscience AG | Zusammensetzung aus einen calcitoninmimetika und einen nsulin-sensibilisator |
| US9457086B2 (en) | 2013-03-05 | 2016-10-04 | Enteris Biopharma, Inc. | Pharmaceuticals for oral delivery |
| CN105722854B (zh) | 2013-11-14 | 2020-08-04 | 关键生物科学有限公司 | 用于治疗疾病和病症的降钙素模拟物 |
| JP2016540762A (ja) | 2013-12-02 | 2016-12-28 | ステルス バイオセラピューティックス コープ | 白斑の治療のための組成物及び方法 |
| WO2015183995A2 (en) | 2014-05-28 | 2015-12-03 | Stealth Peptides International, Inc. | Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof |
| EP3502132A1 (de) | 2014-05-28 | 2019-06-26 | Stealth BioTherapeutics Corp | Therapeutische zusammensetzungen mit kleinen therapeutischen molekülen und verwendungen davon |
| US10627392B2 (en) | 2014-06-17 | 2020-04-21 | Stealth Biotherapeutics Corp | Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening |
| GB201500263D0 (en) | 2015-01-08 | 2015-02-25 | Keybioscience Ag | Calcitonin analogues for treating diseases and disorders |
| DK3244878T3 (da) | 2015-01-12 | 2022-10-17 | Enteris Biopharma Inc | Faste orale sammensætningsformer |
| GB201704429D0 (en) | 2017-03-21 | 2017-05-03 | Keybioscience Ag | Calcitonin mimetics for treating diseases and disorders |
| GB201707955D0 (en) | 2017-05-18 | 2017-07-05 | Keybioscience Ag | Dual amylin and calcitonin receptor agonists for treating diseases and disorders |
| GB201813677D0 (en) | 2018-08-22 | 2018-10-03 | Keybioscience Ag | Calcitonin mimetics for treating diseases and disorders |
| GB201813678D0 (en) | 2018-08-22 | 2018-10-03 | Keybioscience Ag | Acylated calcitonin mimetics |
| WO2021026854A1 (zh) * | 2019-08-15 | 2021-02-18 | 中国科学院微生物研究所 | 一种酶催化的蛋白质c-端选择性酰肼化修饰方法 |
| GB202001024D0 (en) | 2020-01-24 | 2020-03-11 | Key Bioscience Ag | Oxyntomodulin mimetics |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3484377D1 (de) * | 1983-06-15 | 1991-05-08 | Celltech Ltd | Peptide, pharmazeutische zusammensetzungen, gene, vektoren, wirtorganismen, verfahren zu deren herstellung und diagnostische reagenzien. |
| DE3327007A1 (de) * | 1983-07-27 | 1985-02-07 | Hoechst Ag, 6230 Frankfurt | Herstellung von polypeptiden mit einem saeureamid-carboxyterminus |
| US6319685B1 (en) * | 1984-09-27 | 2001-11-20 | Unigene Laboratories, Inc. | Alpha-amidating enzyme compositions and processes for their production and use |
| US4708934A (en) * | 1984-09-27 | 1987-11-24 | Unigene Laboratories, Inc. | α-amidation enzyme |
| JPS6229997A (ja) * | 1985-04-08 | 1987-02-07 | Sankyo Co Ltd | Ｃ末端にプロリンアミドを有するペプチドの製法 |
| JPS62177184A (ja) * | 1986-01-29 | 1987-08-04 | Toyota Motor Corp | 鋳鉄製内燃機関用シリンダヘツドおよびその製造方法 |
| JPH0775541B2 (ja) * | 1986-06-07 | 1995-08-16 | 壽之 松尾 | Ｃ末端アミド化酵素及びその製造方法 |
| EP0249477A3 (de) * | 1986-06-12 | 1988-01-20 | Immunex Corporation | Funktionelle rekombinante Analog-Polypeptide ohne hydrophobe Aminosäuren |
| JP2598050B2 (ja) * | 1987-07-17 | 1997-04-09 | サントリー株式会社 | Ｃ−末端α−アミド化酵素 |
| US5789234A (en) * | 1987-08-14 | 1998-08-04 | Unigene Laboratories, Inc. | Expression systems for amidating enzyme |
| US6255067B1 (en) * | 1987-09-15 | 2001-07-03 | The Johns Hopkins University | cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM) |
| JP2535398B2 (ja) * | 1989-01-17 | 1996-09-18 | サントリー株式会社 | アミド化ペプチドの製造方法 |
| JP2845468B2 (ja) * | 1989-01-17 | 1999-01-13 | サントリー株式会社 | ヒト甲状腺由来Ｃ―末端α―アミド化酵素 |
-
1989
- 1989-02-06 US US07/307,366 patent/US5789234A/en not_active Expired - Lifetime
-
1990
- 1990-01-22 HU HU26/90A patent/HU220464B1/hu not_active IP Right Cessation
- 1990-02-01 ES ES90301034T patent/ES2235149T3/es not_active Expired - Lifetime
- 1990-02-01 DE DE69034179T patent/DE69034179T2/de not_active Expired - Lifetime
- 1990-02-01 EP EP90301034A patent/EP0382403B1/de not_active Expired - Lifetime
- 1990-02-01 DK DK90301034T patent/DK0382403T3/da active
- 1990-02-01 AT AT90301034T patent/ATE283922T1/de not_active IP Right Cessation
- 1990-02-05 RU SU4743221A patent/RU2129606C1/ru active
- 1990-02-05 NO NO90900531A patent/NO900531L/no unknown
- 1990-02-05 CA CA002009306A patent/CA2009306C/en not_active Expired - Lifetime
- 1990-02-05 FI FI900554A patent/FI110517B/fi active IP Right Grant
- 1990-02-06 KR KR1019900001434A patent/KR0157983B1/ko not_active Expired - Fee Related
- 1990-02-06 JP JP2026989A patent/JPH0771498B2/ja not_active Expired - Lifetime
-
1994
- 1994-01-28 LT LTIP1829A patent/LT4077B/lt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2235149T3 (es) | 2005-07-01 |
| CA2009306A1 (en) | 1990-08-06 |
| LT4077B (en) | 1996-12-27 |
| NO900531D0 (no) | 1990-02-05 |
| FI900554A0 (fi) | 1990-02-05 |
| HU900226D0 (en) | 1990-03-28 |
| RU2129606C1 (ru) | 1999-04-27 |
| CA2009306C (en) | 2002-04-09 |
| FI110517B (fi) | 2003-02-14 |
| JPH0771498B2 (ja) | 1995-08-02 |
| JPH0541982A (ja) | 1993-02-23 |
| DE69034179D1 (de) | 2005-01-05 |
| EP0382403A2 (de) | 1990-08-16 |
| HU220464B1 (hu) | 2002-02-28 |
| DK0382403T3 (da) | 2005-03-21 |
| LTIP1829A (en) | 1995-08-25 |
| EP0382403A3 (de) | 1991-04-10 |
| US5789234A (en) | 1998-08-04 |
| EP0382403B1 (de) | 2004-12-01 |
| KR0157983B1 (ko) | 1998-11-16 |
| DE69034179T2 (de) | 2005-12-01 |
| KR900013078A (ko) | 1990-09-03 |
| HUT54414A (en) | 1991-02-28 |
| ATE283922T1 (de) | 2004-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO900531D0 (no) | Ekspresjonssystemer for amideringsenzymer. | |
| WO2001014539A3 (en) | Methods and compositions for the construction and use of fusion libraries | |
| WO1994003616A3 (fr) | Vecteur de clonage et/ou de sequençage | |
| EP0596979A4 (en) | Recombinant plant viral nucleic acids. | |
| AU2812484A (en) | Dna vectors and there use in recombinant dna technology | |
| ATE341627T1 (de) | Als lerk6 bezeichnetes cytokin | |
| FI923758A0 (fi) | Expressionssystem. | |
| DE3770915D1 (de) | Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli. | |
| BR9609102A (pt) | Construção de dna recombinante e vetor útil para produzir transformantes de células de hospedeiro bacteriano | |
| EP0331356A3 (de) | Expression von HIV-bindenden Proteinen | |
| BG50281A3 (bg) | Метод за получаване на рекомбинантн днк експресионен вектор | |
| FI971275A7 (fi) | Inaktivoidun IVa2-geenin käsittävät epätäydelliset yhdistelmä-DNA-tekn iset adenovirukset | |
| ATE346498T1 (de) | Als lerk6 bezeichnetes cytokin | |
| DK169890A (da) | Kloning og ekspression af et protein, som modulerer det cellulaere respons paa type i interferon | |
| GR3006045T3 (de) | ||
| AU2176997A (en) | Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use | |
| MY107451A (en) | Cloning and expression of a rhoptry associated protein of p.falciparum | |
| SE8800981D0 (sv) | A recombinant fusion protein, its use and a recombinant vector | |
| IT1262957B (it) | Procedimento di produzione della proteina sv-iv ricombinante e proteina sv-iv ricombinante. | |
| IT1261676B (it) | Proteine ricombinanti, vettori per l'espressione e loro usi. | |
| WO2001014418A3 (en) | p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF | |
| DE3688974D1 (de) | Expressionssysteme zur überproduktion gewünschter proteine. | |
| SE9101740D0 (sv) | Nya dna fragment och sekvenser | |
| IT1251680B (it) | Clonaggio e sequenziamento dell'operone srfa di bacillus subtilis che codifica il complesso multienzimatico surfattina sintetasi |